Form 4: Stryker Corp CFO Glenn Boehnlein Executes Stock Option and Disposes of Shares

Glenn Boehnlein, CFO of Stryker Corp, exercised stock options and disposed of shares to cover tax obligations.

Summary

• On December 31, 2024, Glenn S. Boehnlein, the Chief Financial Officer of Stryker Corp, executed a transaction involving company stock.
• Boehnlein exercised an employee stock option to acquire 300 shares of common stock at a price of $122.51 per share.
• Simultaneously, Boehnlein disposed of 203 shares of common stock at a price of $362.26 per share to satisfy tax obligations.
• Following these transactions, Boehnlein directly owns 5,128 shares of Stryker common stock and indirectly owns 1,554 shares through a 401K.
• Boehnlein also holds derivative securities, specifically 9,015 employee stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common among corporate executives. These filings are monitored by investors to gain insights into management's perspective on the company's stock and future prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies like Stryker, similar to filings made by executives at Medtronic (MDT), Johnson & Johnson (JNJ), and Zimmer Biomet (ZBH).
• The exercise of stock options and subsequent sale of shares to cover taxes is a common financial planning strategy among executives in the medical device industry.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• Shareholders may view insider transactions as a signal of management's confidence (or lack thereof) in the company, but this specific transaction appears to be routine.

Key Dates